Educating pharmacy students through a pandemic: Reflecting on our COVID-19 experienceRESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACYIF2.82022-07-015OAAI
Dysregulation of Specialized Delay/Interference-Dependent Working Memory Following Loss of Dysbindin-1A in Schizophrenia-Related PhenotypesNEUROPSYCHOPHARMACOLOGYIF7.12016-12-1615OAAI
Epistatic and Independent Effects on Schizophrenia-Related Phenotypes Following Co-disruption of the Risk Factors Neuregulin-1 x DISC1SCHIZOPHRENIA BULLETINIF4.82016-09-0914OAAI
Phenotypic effects of repeated psychosocial stress during adolescence in mice mutant for the schizophrenia risk gene neuregulin-1: A putative model of gene x environment interactionBRAIN BEHAVIOR AND IMMUNITYIF7.62012-05-0182PREAI
PHENOTYPIC EFFECTS IN ADULTHOOD OF REPEATED PSYCHOSOCIAL STRESS DURING ADOLESCENCE INMICE MUTANT FOR THE SCHIZOPHRENIA RISK GENE NEUREGULIN-1: A PUTATIVE MODEL OF GENE x ENVIRONMENT INTERACTIONSCHIZOPHRENIA RESEARCHIF3.52012-04-010PREAI
Examination of nociceptive behaviour and stress reactivity in susceptibility gene mutant models of schizophreniaEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72010-08-010PREAI
Chronic Adolescent Exposure to Δ-9-Tetrahydrocannabinol in COMT Mutant Mice: Impact on Psychosis-Related and Other PhenotypesNEUROPSYCHOPHARMACOLOGYIF7.12010-07-1486OAAI
DIFFERENTIAL EFFECTS OF CHRONIC ADOLESCENT VS. ADULT THC EXPOSURE IN COMT KNOCKOUT MICE ON PHENOTYPES RELEVANT TO PSYCHOSISSCHIZOPHRENIA RESEARCHIF3.52010-04-010PREAI
Structural brain abnormalities and altered sensitivity to psychotomimetic drugs in neuregulin-1 knockout miceEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72009-09-010PREAI
The role of human demographic history in determining the distribution and frequency of transferase-deficient galactosaemia mutationsHEREDITYIF3.92009-07-2917OAAI
Phenotype of spontaneous orofacial dyskinesia in neuregulin-1 'knockout' micePROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRYIF3.92009-03-018PREAI
Disruption of orofacial movement topographies in congenic mutants with dopamine D5 but not D4 receptor or DARPP-32 transduction 'knockout'EUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72006-08-0114OAAI
Ethologically based resolution of D2-like dopamine receptor agonist-versus antagonist-induced behavioral topography in dopamine- and adenosine 3′, 5′-monophosphate-regulated phosphoprotein of 32 kDa knockout mutants congenic on the C57BL/6 genetic backgroundJOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICSIF3.82004-09-0113PREAI
Frequency distribution of the Los Angeles and Duarte galactose-1-phosphate uridyltransferase variant alleles in the Irish populationMOLECULAR GENETICS AND METABOLISMIF3.52004-08-015PREAI
Identification of sequence variation in the galactose-1-phosphate uridyl transferase gene by dHPLCMOLECULAR GENETICS AND METABOLISMIF3.52004-02-016PREAI
Topographical evaluation of spontaneous and agonist-induced behaviour in mutants with congenic dopamine D4 versus D5 receptor knockoutEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72004-01-012PREAI
Topographical assessment of ethological and dopamine receptor agonist-induced behavioral phenotype in mutants with congenic DARPP-32 'knockout'NEUROPSYCHOPHARMACOLOGYIF7.12003-06-0525OAAI
Genetic diversity within the R408W phenylketonuria mutation lineages in EuropeHUMAN MUTATIONIF3.72003-03-1931PREAI
Gene expression differences between the microsatellite instability (MIN) and chromosomal instability (CIN) phenotypes in colorectal cancer revealed by high-density cDNA array hybridization (vol 21, pg 3253, 2002)ONCOGENEIF7.32002-11-061OAAI
The mutation spectrum of hyperphenylalaninaemia in the Republic of Ireland: the population history of the Irish revisitedEUROPEAN JOURNAL OF HUMAN GENETICSIF4.62002-08-1323OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向